Oppenheimer downgraded Roper Technologies (ROP) to Perform from Outperform without a price target The company reported mixed fiscal Q4 results with a softer than expected fiscal 2026 outlook, the analyst tells investors in a research note. The firm says that while the guidance looks conservative, investors will remain cautious on the implied second half of the year improvement. Oppenheimer expects the shares to be range-bound on Roper’s lack of near-term catalysts and organic growth challenges. The stock closed Tuesday down 10% to $369.27.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ROP:
- Roper Technologies downgraded to Perform from Outperform at Oppenheimer
- Roper Technologies price target lowered to $550 from $650 at Truist
- Midday Fly By: CMS proposal sinks insurers, UnitedHealth reports mixed Q4
- Roper Technologies downgraded to Hold from Buy at Melius Research
- Morning Movers: Managed care group slide after CMS notice
